Our Stories
Latest News
Innovation
Caring & Giving
Personal Stories
Health & Wellness
Our Heritage
Our Company
About J&J
Our Credo
Our Leadership Team
Corporate Governance
Diversity & Inclusion
Empowering Women
Innovation at J&J
Office of the Chief Medical Officer
J&J Health and Wellness Solutions
Policies & Statements
Code of Business Conduct
Corporate Reports
Products
Consumer Products
Medical Devices
Pharmaceutical Products
Procurement
Value Pillars
Supplier Diversity
Supplier Standards
Careers
What We Do
How We Hire
Job Spotlight
Employee Benefits
Students
Innovation
Career Stories
Media Center
Investors
Corporate Governance
Quarterly Results
SEC Filings
News Releases
Pharmaceutical Pipeline
2016 Health for Humanity Report
Stock Information
Webcasts & Presentations
Our Societal Impact
Global Community Impact
Global Public Health
Global Environmental Health
Citizenship & Sustainability Reporting
Follow Us
Facebook
Twitter
YouTube
LinkedIn
Explore more Johnson & Johnson sites:
Australia
Argentina
Brazil
Canada
Chile
China
Colombia
Costa Rica
Ecuador
Germany
India
Italy
Japan
Mexico
New Zealand / Pacific
Paraguay
Peru
Philippines
Russia
Switzerland
German
English
French
Italian
Uruguay
United States
Venezuela
Ebola
Read the Press Release
Johnson & Johnson Announces New U.S. Support for Ebola Vaccine Development
Two Milestones for Ebola Vaccine Program
Developing the Tools to Stop Ebola
New Ebola Study Focused on Helping Halt Future Outbreaks
Ebola Virus News
Innovation
March 14, 2017
Investigational Ebola Vaccine Regimen Induced Durable Immune Response 1 Year After Vaccination in Phase 1 Study
Global Public Health
September 29, 2016
Photo Gallery: Staying at Zero in Sierra Leone
Global Public Health
October 26, 2016
Video: The Business Debate - Johan Van Hoof on Johnson & Johnson's Commitment to Combat Ebola
Innovation
March 15, 2016
The Race to Create an Ebola Vaccine
Global Public Health
Start of Clinical Trial in Sierra Leone
Global Public Health
January 16, 2015
Johnson & Johnson Announces Formation of Ebola Vaccine Development Consortia
Media Coverage
Fox News: "A One-Two Punch Against Ebola"
Reuters: Two-Part Ebola Vaccine Offers Long-Lasting Protection
STAT: J&J Begins Testing Multivalent Ebola Vaccine
Bloomberg: Ebola Vaccine Has Promise
More From Johnson & Johnson
Personal Stories
"I’ve Always Considered Myself a 'MacGyver' Nurse": How One Woman Is Propelling Healthcare Forward
Health & Wellness
4 Things We Now Know About Treatment-Resistant Depression
Innovation
9 Ways Johnson & Johnson Has Revolutionized Baby Care
